Table 1.
Demographic profile of patients involved in the study (n = 103)
| n (%) | |
|---|---|
| Age (years) | 56.34 ± 9.79 |
| Menopausal status | |
| Pre menopausal | 19 (18.4) |
| Post menopausal | 84 (81.6) |
| Histological type | |
| Endometrioid | 87 (84.5) |
| Serous | 9 (8.7) |
| Clear cell | 1 (1) |
| Carcinosarcoma | 6 (5.8) |
| Grade | |
| Grade I | 41 (39.8) |
| Grade II | 40 (38.8) |
| Grade III | 22 (21.4) |
| Myometrial invasion | |
| Limited to endometrium | 6 (5.8) |
| Less than half of myometrium | 38 (36.9) |
| More than half of myometrium | 59 (57.3) |
| Cervical invasion | |
| Present | 26 (25.2) |
| Absent | 77 (74.8) |
| Adnexal involvement | |
| Present | 11 (10.7) |
| Absent | 92 (89.3) |
| Nodal status | |
| N0 | 96 (93.2) |
| N1 | 6 (5.8) |
| N2 | 1 (1) |
| Lymphovascular invasion | |
| Present | 8 (7.8) |
| Absent | 95 (92.2) |
| T stage | |
| T1 | 72 (69.9) |
| T2 | 17 (16.5) |
| T3 | 10 (9.7) |
| T4 | 4 (3.9) |
| FIGO stage | |
| Stage IA | 40 (38.8) |
| Stage IB | 31 (30.1) |
| Stage II | 18 (17.5) |
| Stage IIIA | 8 (7.8) |
| Stage IIIB | 2 (1.9) |
| Stage IV | 4 (3.9) |